AxoSim Appoints Two Biotech Industry Veterans as Co-Chairs
Serial Entrepreneurs Dale Pfost and David Weiner Bring Broad Expertise as AxoSim Expands Its Leadership in Human Organoid Technologies Designed to Make...
Source: globenewswire.com
📰 Advent Life Sciences News
Advent Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Advent Life Sciences. Real-time updates on events, politics, business and more.
British Patient Capital invests £10m into cancer-focused biotech
British Patient Capital, the venture capital subsidiary of the British Business Bank, has invested £10m into Curve Therapeutics.
Source: cityam.com
Argá Medtech closes oversubscribed Series B funding for pulsed field ablation tech
Argá Medtech today announced it closed a €54 million oversubscribed Series B funding round to support its pulsed field ablation technology.
San Diego United States David Neale Earlybird Health Advent Life Sciences Coherent Sine Burst Electroporation
Source: massdevice.com
Curve Therapeutics Raises £40.5M in Series A Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
United Kingdom Simon Kerry Advent Life Sciences Curve Therapeutics United Kingdom Based Pfizer Ventures
Source: finsmes.com
Curve Therapeutics raises £40.5m to 'turbocharge' discovery platform
Curve Therapeutics, a biotech developing an intracellular screening platform addressing complex disease targets, has closed its £40.5 million Series A financing.
Source: biopharma-reporter.com
Curve Therapeutics raises £40.5 million to turbocharge discovery platform and advance breakthrough pipeline
Curve Therapeutics raises £40.5 million to turbocharge discovery platform and advance breakthrough pipeline
United Kingdom Simon Kerry Ali Tavassoli Advent Life Sciences Pfizer Ventures Columbus Venture Partners
Source: pharmiweb.com
Artax Announces First Patient Dosed in Phase 2a Psoriasis Trial Evaluating AX-158
/PRNewswire/ -- Artax Biopharma, Inc., a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, today announces...
Source: prnewswire.com
Nalu Medical Raises $65M in Equity Financing
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
Source: finsmes.com
Nalu Medical raises $65M for neurostim tech
Nalu Medical announced today that it closed a $65 million equity financing to support its minimally invasive neurostimulation product.
Source: massdevice.com
Amphista Therapeutics Achieves First Discovery Milestone in Collaboration with Bristol Myers Squibb
CAMBRIDGE, England, May 4, 2023 /PRNewswire/ -- Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the delivery of the first discovery
United Kingdom Alessio Ciulli Lynn Granito Nicola Thompson Advent Life Sciences Amphista Therapeutics
Source: finanznachrichten.de